Janssen Biologics B.V.
Records under this name other than patents Janssen Biologics B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Janssen Biologics B.V.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,775,014 | Multiparameter Materials, Methods and Systems for Enhanced Bioreactor Manufacture now held by Janssen Biotech, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 12,534,524 | Manufacturing Methods for Producing Anti-TNF Antibody Compositions now held by Janssen Sciences Ireland Unlimited Company In force · High confidence | In force | High confidence | |
| US 11,149,085 | Manufacturing Methods to Control C-Terminal Lysine, Galactose and Sialic Acid Content in Recombinant Proteins now held by Janssen Biotech, Inc. Lapsed on the fee record Ended Oct 19, 2025 · High confidence | Lapsed on the fee record | Ended Oct 19, 2025 | High confidence |
| 14/207,915 | Manufacturing Methods to Control C-Terminal Lysine, Galactose and Sialic Acid Content in Recombinant Proteins now held by Janssen Biotech, Inc. Abandoned Abandoned Jan 11, 2016 | Abandoned | Abandoned Jan 11, 2016 | |
| 17/489,744 | Manufacturing Methods To Control C-Terminal Lysine, Galactose And Sialic Acid Content In Recombinant Proteins now held by Janssen Biotech, Inc. Abandoned Abandoned Feb 24, 2024 | Abandoned | Abandoned Feb 24, 2024 |